Columns & Departments
Practice Tip
Discussion of personality disorders in divorce, and e-filing in Connecticut.
IP Outsourcing
The growing demand for IP to be at the center of commercial strategy, together with a squeeze on resources and budgets, has resulted in many in-house teams looking for alternative ways to organize and manage their IP work.
Features
Court: Condo Association Has the Right to Amend Bylaws to Bar Smoking Within Individual Units
In February 2014, a Westchester County condo association amended its bylaws to bar smoking everywhere on the condominium property, including inside individual units. One unit ownercontinued to smoke in his unit. Herein is a discussion of the litigation that followed.
Features
Transforming e-Discovery Into a Standard Business Process
In recent years, the need to treat e-discovery as a repeatable, streamlined process has been well-evidenced by a series of U.S. court opinions citing a wide range of e-discovery failures, including those related to preservation of electronically stored information (ESI), document productions and identification of potential custodians.
Features
Strategic Content Management to Maximize Net Revenue
Strategic contract management and the deployment of the right supporting technology can help organizations extract maximum value from their contracts. Many organizations are not there yet, however, according to a recent survey.
CA Employers, Heads Up!
Beginning in 2015, California employers will be required by law to provide paid sick leave to employees. Because California is often a bellwether state for changes in others, this legislation is of national interest. Will your state be next?
Features
Attorney Fees Under ERISA
After broaching the issue in a nonprecedential opinion released last summer, the U.S. Court of Appeals for the Third Circuit suggested during arguments on Oct. 21 that it might soon answer definitively whether the catalyst theory for recovering attorney fees applies in ERISA cases.
Columns & Departments
Case Notes
In a recent decision subject to multiple flaws, the United States District Court for the District of Massachusetts refused to dismiss a suit against the manufacturer of an investigational drug and medical device used in a clinical trial based on the allegedly inadequate warnings the clinical trial investigator provided to patients in obtaining their informed consent to the trial.
The Bumpy Road: Tort Reform in New Jersey
In New Jersey, the AOM Statute, although reducing the number of medical malpractice lawsuits filed overall, has created virtually as much litigation by way of motion practice and appellate practice; these make up for the reduced number of lawsuits.
Features
Linking Business Development to Partner Compensation
In recent years, as client fee pressure has increased and client loyalty has decreased, law firms are investing significant time and money in business development programs. Some partners receive training to dust off selling skills that were largely unnecessary during a time of plenty. Other partners receive training, then individualized coaching, then more training, then more coaching, in an often-futile attempt to turn everyone into a capable rainmaker.
Need Help?
- Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
- Need other assistance? email Customer Service or call 1-877-256-2472.
MOST POPULAR STORIES
- Meet the Lawyer Working on Inclusion Rider LanguageAt the Oscars in March, Best Actress winner Frances McDormand made “inclusion rider” go viral. But Kalpana Kotagal, a partner at Cohen Milstein Sellers & Toll had already worked for months to write the language for such provisions. Kotagal was developing legal language for contract provisions that Hollywood's elite could use to require studios and other partners to employ diverse workers on set.Read More ›
- Protecting Innovation in the Cyber World from Patent TrollsWith trillions of dollars to keep watch over, the last thing we need is the distraction of costly litigation brought on by patent assertion entities (PAEs or "patent trolls"), companies that don't make any products but instead seek royalties by asserting their patents against those who do make products.Read More ›
- From the PTO to the FDA: What to Consider When Branding Clinical TrialsThe legal implications of branding generally arise initially for companies during the process of selecting a company name and any initial product or service names. For drug development companies, however, careful consideration should also be paid to the implications of branding a clinical trial.Read More ›
- Disconnect Between In-House and Outside Counsel'Disconnect Between In-House and Outside Counsel is a continuation of the discussion of client expectations and the disconnect that often occurs. And although the outside attorneys should be pursuing how inside-counsel actually think, inside counsel should make an effort to impart this information without waiting to be asked.Read More ›